Evidence map›Paper›PMID 30047027›Full record

ReviewPaediatric drugs2018

Methadone for Pain Management in Children with Cancer.

Catherine Habashy, Erin Springer, Elizabeth A Hall, Doralina L Anghelescu

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Paediatric drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06940570 (A Randomized Single Center Trial to Determine the Efficacy of Methadone as a First Line Agent in the Reduction and Treatment of Pain in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06940570 phase3suspendednot on this mapstarted 2028, after this paper: background citation

A Randomized Single Center Trial to Determine the Efficacy of Methadone as a First Line Agent in the Reduction and Treatment of Pain in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation

TypeinterventionalSponsorUniversity of Texas Southwestern Medical CenterRan2028 to 2029Enrolled60ConditionsLeukemia, Aplastic Anemia, Bone Marrow Failure Syndromes, SCIDArmsPCA plus methadone (Experimental), PCA Alone (SOC)
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Reducing pain in children with cancer at home: a feasibility study of the KLIK pain monitor app.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  8. Alleviating Terminal Pediatric Cancer Pain.Children (Basel, Switzerland) · 2021
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Methadone in Cancer Pain.Indian journal of palliative care
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Catherine HabashyDivison of Hospitalist Medicine, Department of Pediatrics, Children's National Medical Center, Washington, DC, 20010, USA.
Erin SpringerDepartment of Anesthesiology and Critical Care Medicine, The Johns Hopkins Hospital, Baltimore, MD, 21287, USA.
Elizabeth A HallPharmaceutical Services, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Doralina L AnghelescuDivision of Anesthesia, Department of Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA. doralina.anghelescu@stjude.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methadone is a synthetic opioid with unique pharmacodynamic and pharmacokinetic properties. It is effective in treating both nociceptive and neuropathic pain, which commonly co-exist in children with cancer. Upon reviewing the literature describing the use of methadone in pediatric oncology patients, publications are limited in number and low in quality of evidence; nevertheless, there is support for the safety and efficacy of methadone in treating pain in children with cancer, particularly when pain is refractory to conventional treatment. Although the risk of life-threatening arrhythmia is commonly cited as an argument against the use of methadone, our review of the literature did not support this finding in children. Further evaluation with prospective studies is warranted to develop evidence-based recommendations for the use of methadone in pediatric oncology.

Indexed as

Analgesics, OpioidCancer PainChildHumansMethadoneNeoplasmsPain ManagementPain MeasurementAnalgesics, OpioidMethadone

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.